The present work aims to prepare and characterize mucoadhesive tablets of Atenolol using different buccoadhesive polymers such as chitosan, carbopol 934, Sodium alginate and HPMC K4M in combinations. The formulation of buccal tablet dose is released at a slow rate due to the presence of the polymers of different concentrations. All the buccal tablet formulations were subjected to pre-compression and post-compression evaluation. In-vitro drug release from the formulations was studied using buffer pH 6.8. From in vitro studies formulations F10, F16, F17, F18 were selected for mucoadhesive studies. Formulations F16, F17, F18 were selected for ex vivo permeation studies using buffer pH 7.4. After all studies formulation F18 containing chitosan, carbopol 934 and HPMC K4M in the ratio of 4: 3: 1 selected as optimized formulation showed zero-order release with optimum buccoadhesive strength and exhibited optimum drug release. FTIR results showed no evidence of interaction between the drug and polymers. The assay of the formulations revealed that the drug content was within the limits. The results indicated that delivery of Atenolol to the systemic circulation via the buccal route.
"synopsis" may belong to another edition of this title.
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The present work aims to prepare and characterize mucoadhesive tablets of Atenolol using different buccoadhesive polymers such as chitosan, carbopol 934, Sodium alginate and HPMC K4M in combinations. The formulation of buccal tablet dose is released at a slow rate due to the presence of the polymers of different concentrations. All the buccal tablet formulations were subjected to pre-compression and post-compression evaluation. In-vitro drug release from the formulations was studied using buffer pH 6.8. From in vitro studies formulations F10, F16, F17, F18 were selected for mucoadhesive studies. Formulations F16, F17, F18 were selected for ex vivo permeation studies using buffer pH 7.4. After all studies formulation F18 containing chitosan, carbopol 934 and HPMC K4M in the ratio of 4: 3: 1 selected as optimized formulation showed zero-order release with optimum buccoadhesive strength and exhibited optimum drug release. FTIR results showed no evidence of interaction between the drug and polymers. The assay of the formulations revealed that the drug content was within the limits. The results indicated that delivery of Atenolol to the systemic circulation via the buccal route. 116 pp. Englisch. Seller Inventory # 9786134937399
Seller: moluna, Greven, Germany
Kartoniert / Broschiert. Condition: New. Seller Inventory # 497399162
Quantity: Over 20 available
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The present work aims to prepare and characterize mucoadhesive tablets of Atenolol using different buccoadhesive polymers such as chitosan, carbopol 934, Sodium alginate and HPMC K4M in combinations. The formulation of buccal tablet dose is released at a slow rate due to the presence of the polymers of different concentrations. All the buccal tablet formulations were subjected to pre-compression and post-compression evaluation. In-vitro drug release from the formulations was studied using buffer pH 6.8. From in vitro studies formulations F10, F16, F17, F18 were selected for mucoadhesive studies. Formulations F16, F17, F18 were selected for ex vivo permeation studies using buffer pH 7.4. After all studies formulation F18 containing chitosan, carbopol 934 and HPMC K4M in the ratio of 4: 3: 1 selected as optimized formulation showed zero-order release with optimum buccoadhesive strength and exhibited optimum drug release. FTIR results showed no evidence of interaction between the drug and polymers. The assay of the formulations revealed that the drug content was within the limits. The results indicated that delivery of Atenolol to the systemic circulation via the buccal route.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 116 pp. Englisch. Seller Inventory # 9786134937399
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The present work aims to prepare and characterize mucoadhesive tablets of Atenolol using different buccoadhesive polymers such as chitosan, carbopol 934, Sodium alginate and HPMC K4M in combinations. The formulation of buccal tablet dose is released at a slow rate due to the presence of the polymers of different concentrations. All the buccal tablet formulations were subjected to pre-compression and post-compression evaluation. In-vitro drug release from the formulations was studied using buffer pH 6.8. From in vitro studies formulations F10, F16, F17, F18 were selected for mucoadhesive studies. Formulations F16, F17, F18 were selected for ex vivo permeation studies using buffer pH 7.4. After all studies formulation F18 containing chitosan, carbopol 934 and HPMC K4M in the ratio of 4: 3: 1 selected as optimized formulation showed zero-order release with optimum buccoadhesive strength and exhibited optimum drug release. FTIR results showed no evidence of interaction between the drug and polymers. The assay of the formulations revealed that the drug content was within the limits. The results indicated that delivery of Atenolol to the systemic circulation via the buccal route. Seller Inventory # 9786134937399
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Development and Evaluation of Bucco Adhesive Controlled Release Delivery | Supraja Nookala (u. a.) | Taschenbuch | Englisch | 2019 | LAP LAMBERT Academic Publishing | EAN 9786134937399 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand. Seller Inventory # 120472122